Whale Large Capital
  • Politics
  • World News
  • Business
  • Investing
  • Politics
  • World News
  • Business
  • Investing

Whale Large Capital

World News

Drugmakers at fault over toxic cough syrup, Indonesia court finds

by August 23, 2024
August 23, 2024
Drugmakers at fault over toxic cough syrup, Indonesia court finds

An Indonesian court ordered two local companies to pay up to 60 million rupiah ($3,850) to each family whose children died of an acute kidney injury or were seriously injured after consuming toxic cough syrup.

More than 200 children in Indonesia died of the injury and about 120 more survived, some of whom lived with disabilities which led to financial hardships for their parents.

Indonesian courts have cited lax oversight by pharmaceutical companies, including local drugmakers and some suppliers, as well as the country’s food and drugs agency (BPOM), in hearings into the poisonings.

In late 2022, more than 20 families launched a civil suit against the agency, the health ministry, and several companies.

Judges at the Central Jakarta court found a drugmaker and a supplier, Afi Farma and CV Samudera Chemical, at fault in the poisonings, according to a ruling released late on Thursday.

The health ministry and the BPOM were cleared of wrongdoing.

The court ordered the companies to pay the parents who brought the suit compensation of 50 million rupiah for children who died and 60 million rupiah for children who were injured.

Parents had asked for 3.4 billion rupiah for each child that died, and 2.2 billion rupiah for survivors. Indonesia’s 2023 gross domestic product per capita was nearly $5,000, data from the country’s Statistics Bureau shows.

Siti Habiba, the lawyer for the parents, said the families were disappointed by the ruling, as the money was given “as though we were beggars.”

“This breaks a lot of the victims’ hearts,” she said, adding the court ignored the parents’ government oversight concerns by not finding the health ministry and the BPOM at fault.

The court document, posted on its website, did not include reasons for the decision.

Afi Farma’s lawyer Reza Wendra Prayogo told Reuters on Friday the firm was “disappointed” with the civil case ruling and the company was still considering its next legal step.

Last year, a criminal court found East Java-based drugmaker Afi Farma guilty of negligence and jailed officials for not testing the ingredients sent by its supplier.

The syrups contained ethylene glycol (EG), a commonly used chemical in products such as brake fluid and antifreeze. A court document from that criminal case said the EG concentration in the syrups reached as high as 99%, where international standards say only 0.1% of EG is safe for consumption.

The company has repeatedly denied negligence.

Reuters could not immediately contact CV Samudera Chemical, an Indonesian soapmaker, whose toxic ingredient made its way to Afi Farma, according to the court document of the Afi Farma criminal case in 2023.

The World Health Organization said the contaminated medicines had also killed children in Gambia and Uzbekistan in 2022.

This post appeared first on cnn.com
0
FacebookTwitterGoogle +Pinterest
previous post
EURUSD and GBPUSD: GBPUSD remains stable in a bullish trend
next post
July home sales break a four-month losing streak as supply rises nearly 20% over last year

You may also like

Trump’s threat to make Canada the 51st state...

January 10, 2025

‘It’s just horror’: Life on the streets of...

March 18, 2025

Netanyahu says he spoke with Trump about need...

December 15, 2024

Georgia suspends talks on joining the EU for...

November 28, 2024

UK police make second arrest in connection with...

May 17, 2025

Gorilla at a Canadian zoo died after worker...

November 22, 2024

Ghana Supreme Court rejects legal challenges to anti-LGBT...

December 18, 2024

As Ukraine batters Russia with daring assaults, firebrand...

June 4, 2025

Three feared dead as India deploys divers, helicopters...

January 7, 2025

Discovery of secret crematoriums at a ranch in...

March 14, 2025

    Subscribe today to receive exclusive access to all our retirement secrets and income strategies, including special financial news and updates from our experts. From time to time, our newsletters feature valuable insights and analysis on the latest financial trends. Don't miss out on these exclusive updates – join our subscription to stay informed!


    By opting in you agree to receive emails from us. Your information is secure and your privacy is protected.



    Latest

    • Obama calls Charlie Kirk’s death ‘horrific,’ blames Trump for fueling division

      September 17, 2025
    • Newsom says he kept in touch with Charlie Kirk since podcast, called him ‘gracious’

      September 17, 2025
    • Turning Point USA expands its merchandise collection with items commemorating Charlie Kirk

      September 17, 2025
    • Patel spars with House Democrats on allegations he’s involved in Epstein ‘cover-up’: ‘Categorically false’

      September 17, 2025
    • FLASHBACK: Mamdani labeled Kirk a ‘far-right extremist’ who should be canceled from speaking in NYC

      September 17, 2025
    • Rand Paul clashes with top Democrat over CDC pushing vaccines on infants

      September 17, 2025

    Categories

    • Business (800)
    • Investing (661)
    • Politics (5,611)
    • World News (3,213)
    • Terms & Conditions
    • Privacy Policy
    • Contact us
    • About us

    Disclaimer: WhaleLargeCapital.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 WhaleLargeCapital.com | All Rights Reserved